Transdermal Patches Market Size
The global transdermal patches market size was valued at USD 7.84 billion in 2024 and is expected to reach USD 11.50 billion by 2032, at a CAGR of 4.90% during the forecast period
The market growth is largely fueled by the increasing launch of innovative drug delivery patches and expanded therapeutic indications
𝐕𝐢𝐬𝐢𝐭 𝐮𝐬 𝐧𝐨𝐰 -
Furthermore, the rising prevalence of chronic conditions such as hypertension, diabetes, and neurological disorders is driving the adoption of non-invasive drug delivery methods. In March 2024, Noven Pharmaceuticals received FDA approval for its Secuad (asenapine) transdermal system, a patch indicated for schizophrenia, which reflects the growing demand for patient-friendly psychiatric treatments and supports long-term market expansion